Conmed Corp. - Ordinary Shares

97.16-2.85-2.85%Vol 314.34K1Y Perf 17.34%
Oct 4th, 2023 16:00 DELAYED
BID92.70 ASK106.14
Open100.11 Previous Close100.01
Pre-Market- After-Market-
 - -%  - -
Target Price
100.50 
Analyst Rating
Moderate Buy 2.00
Potential %
3.92 
Finscreener Ranking
     42.09
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
     41.66
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★+     39.97
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
★★+     42.18
Price Range Ratio 52W %
38.69 
Earnings Rating
Neutral
Market Cap2.99B 
Earnings Date
25th Oct 2023
Alpha-0.00 Standard Deviation0.11
Beta1.39 

Today's Price Range

96.38101.34

52W Range

71.09138.47

5 Year PE Ratio Range

25.30530.40

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
2.52%
1 Month
-9.48%
3 Months
-25.45%
6 Months
-3.84%
1 Year
17.34%
3 Years
26.48%
5 Years
31.47%
10 Years
209.66%

TickerPriceChg.Chg.%
CNMD97.16-2.8500-2.85
AAPL173.661.26000.73
GOOG136.272.97002.23
MSFT318.965.56501.78
XOM111.50-4.3300-3.74
WFC38.970.30000.78
JNJ155.520.18000.12
FB196.640.99000.51
GE108.851.09001.01
JPM143.350.64000.45
Financial StrengthValueIndustryS&P 500US Markets
1.10
2.80
0.59
1.45
-0.10
Leverage Ratio 2.80
ProfitabilityValueIndustryS&P 500US Markets
55.70
-0.30
6.10
4.80
-13.49
RevenueValueIndustryS&P 500US Markets
794.61M
26.07
3.46
4.94
DividendsValueIndustryS&P 500US Markets
0.84
0.80
0.00
0.00
Payout ratio44.00
Earnings HistoryEstimateReportedSurprise %
Q02 20230.790.835.06
Q01 20230.600.6610.00
Q04 20220.930.42-54.84
Q03 20220.750.772.67
Q02 20220.760.760.00
Q01 20220.620.7012.90
Q04 20211.051.071.90
Q03 20210.770.803.90
Earnings Per EndEstimateRevision %Trend
9/2023 QR0.83-1.19Negative
12/2023 QR1.153.60Positive
12/2023 FY3.471.76Positive
12/2024 FY4.381.62Positive
Next Report Date25th Oct 2023
Estimated EPS Next Report0.83
Estimates Count7
EPS Growth Next 5 Years %27.90
Volume Overview
Volume314.34K
Shares Outstanding30.74K
Shares Float30.44M
Trades Count7.26K
Dollar Volume30.58M
Avg. Volume340.15K
Avg. Weekly Volume362.56K
Avg. Monthly Volume321.10K
Avg. Quarterly Volume336.79K

Conmed Corp. - Ordinary Shares (NASDAQ: CNMD) stock closed at 100.01 per share at the end of the most recent trading day (a 0.69% change compared to the prior day closing price) with a volume of 444.39K shares and market capitalization of 2.99B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 3400 people. Conmed Corp. - Ordinary Shares CEO is Curt R. Hartman.

The one-year performance of Conmed Corp. - Ordinary Shares stock is 17.34%, while year-to-date (YTD) performance is 12.83%. CNMD stock has a five-year performance of 31.47%. Its 52-week range is between 71.09 and 138.47, which gives CNMD stock a 52-week price range ratio of 38.69%

Conmed Corp. - Ordinary Shares currently has a PE ratio of -31.70, a price-to-book (PB) ratio of 3.98, a price-to-sale (PS) ratio of 3.65, a price to cashflow ratio of 36.30, a PEG ratio of -1.14, a ROA of -4.38%, a ROC of -4.13% and a ROE of -12.20%. The company’s profit margin is -13.49%, its EBITDA margin is 6.10%, and its revenue ttm is $794.60 Million , which makes it $26.07 revenue per share.

Of the last four earnings reports from Conmed Corp. - Ordinary Shares, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.83 for the next earnings report. Conmed Corp. - Ordinary Shares’s next earnings report date is 25th Oct 2023.

The consensus rating of Wall Street analysts for Conmed Corp. - Ordinary Shares is Moderate Buy (2), with a target price of $100.5, which is +3.92% compared to the current price. The earnings rating for Conmed Corp. - Ordinary Shares stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Conmed Corp. - Ordinary Shares has a dividend yield of 0.84% with a dividend per share of $0.80 and a payout ratio of 44.00%.

Conmed Corp. - Ordinary Shares has a Sell technical analysis rating based on Technical Indicators (ADX : 8.65, ATR14 : 2.70, CCI20 : -91.05, Chaikin Money Flow : -0.20, MACD : -3.10, Money Flow Index : 34.64, ROC : -7.12, RSI : 36.66, STOCH (14,3) : 23.00, STOCH RSI : 0.88, UO : 41.64, Williams %R : -77.00), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Conmed Corp. - Ordinary Shares in the last 12-months were: Berge Terence (Option Excercise at a value of $1 040 927), Berge Terence (Sold 13 300 shares of value $1 685 415 ), Brent Lalomia (Option Excercise at a value of $0), Bronson David (Option Excercise at a value of $0), Cohen Heather (Option Excercise at a value of $164 650), Concannon Brian (Option Excercise at a value of $0), Concannon Brian (Sold 2 884 shares of value $363 756 ), Council Laverne (Option Excercise at a value of $0), Curt R. Hartman (Sold 11 000 shares of value $1 064 079 ), Daniel S. .Jonas (Option Excercise at a value of $1 694 484), Daniel S. .Jonas (Sold 20 400 shares of value $2 261 193 ), Daniel S. Jonas (Option Excercise at a value of $717 584), Daniel S. Jonas (Sold 10 400 shares of value $1 000 104 ), Farkas Charles (Option Excercise at a value of $0), Garner Todd (Option Excercise at a value of $1 746 045), Garner Todd (Sold 34 500 shares of value $3 129 803 ), Jaclyn Peterson (Option Excercise at a value of $0), John D. Ferrell (Option Excercise at a value of $71 281), John D. Ferrell (Sold 1 700 shares of value $224 077 ), Lalomia Brent (Option Excercise at a value of $0), Lande Jerome (Option Excercise at a value of $0), Pelletier Johonna (Option Excercise at a value of $1 494 103), Pelletier Johonna (Sold 18 617 shares of value $2 353 831 ), Peters Stanley (Sold 0 shares of value $-419 300 ), Peters Stanley (Sold 10 000 shares of value $1 230 530 ), Peterson Jaclyn (Sold 0 shares of value $0 ), Schwarzentraub Barbara (Option Excercise at a value of $0), Shagory Peter (Option Excercise at a value of $346 753), Shagory Peter (Sold 2 442 shares of value $312 576 ), Todd W. Garner (Sold 0 shares of value $-1 746 045 ), Todd W. Garner (Sold 34 500 shares of value $3 129 834 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (37.50 %)
4 (44.44 %)
4 (44.44 %)
Moderate Buy
2 (25.00 %)
2 (22.22 %)
2 (22.22 %)
Hold
3 (37.50 %)
3 (33.33 %)
3 (33.33 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.00
Moderate Buy
1.89
Moderate Buy
1.89

Conmed Corp. - Ordinary Shares

Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgery. The firm currently reports through two reporting units, orthopedic surgery (52% of 2018 sales) and general surgery (48%). From a geographic perspective the firm is U.S. centric, with domestic sales accounting for 52% of revenue, EMEA accounting for 19%, APAC at 17%, and the non-U.S. Americas region driving the remaining 12%.

CEO: Curt R. Hartman

Telephone: +1 727 392-6464

Address: 11311 Concept Boulevard, Largo 33773, FL, US

Number of employees: 3 400

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

54%46%

Bearish Bullish

54%46%

Bearish Bullish

51%49%

 

TipRanks News for CNMD


News

Stocktwits